BridgeBio Pharma, Inc. BBIO
74.57 USD -3.32 (-4.26%)
Nov 5, 2026, 2:32 PM EST
74.43 Day range 78.58
61.80 52-week range 90.17
- YTD
- -2.51%
- 1 year
- +19.01%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 502.08M | 221.90M | 9.30M | 77.65M | 69.72M | |
| 502.08M | 221.90M | 9.30M | 77.65M | 69.72M | |
| 20.96M | 3.88M | 2.45M | 3.43M | 3.11M | |
| 481.11M | 218.02M | 6.86M | 74.21M | 66.60M | |
| 1.00B | 811.00M | 614.23M | 586.42M | 643.23M | |
| 451.95M | 506.46M | 455.71M | 399.46M | 451.02M | |
| 531.23M | 288.93M | 150.59M | 143.19M | 192.21M | |
| -523.41M | -592.97M | -607.37M | -512.20M | -576.63M | |
| 53.10M | 90.99M | 81.29M | 80.44M | 46.78M | |
| 435.00K | 1.15M | 0 | 0 | 0 | |
| -724.93M | -535.76M | -643.20M | -481.18M | -562.54M | |
| -724.93M | -535.76M | -643.20M | -481.18M | -562.54M | |
| -724.93M | -535.76M | -643.20M | -481.18M | -562.54M | |
| -732.94M | -543.35M | -653.25M | -484.65M | -586.45M | |
| -8.01M | -7.58M | -10.05M | -3.47M | -23.91M | |
| -3.78 | -2.88 | -3.95 | -3.26 | -3.90 | |
| -3.78 | -2.88 | -3.95 | -3.26 | -3.90 | |
| -3.78 | -2.88 | -3.95 | -3.26 | -3.90 | |
| -671.39M | -443.62M | -561.91M | -400.75M | -515.76M | |
| -671.39M | -443.62M | -561.91M | -400.75M | -515.76M | |
| 191.53M | 186.08M | 162.79M | 147.47M | 144.36M | |
| 191.53M | 186.08M | 162.79M | 147.47M | 144.36M |